Citation: Ef. Fox et al., CYTOMEGALOVIRUS PP65 ANTIGENEMIA AS AN INDICATOR OF END-ORGAN DISEASEIN AIDS, International journal of STD & AIDS, 9(9), 1998, pp. 545-547
Authors:
BREATHNACH AS
DERUITER A
HOLDSWORTH GMC
BATEMAN NT
OSULLIVAN DGM
REES PJ
SNASHALL D
MILBURN HJ
PETERS BS
WATSON J
DROBNIEWSKI FA
FRENCH GL
Citation: As. Breathnach et al., AN OUTBREAK OF MULTI-DRUG-RESISTANT TUBERCULOSIS IN A LONDON TEACHINGHOSPITAL, The Journal of hospital infection, 39(2), 1998, pp. 111-117
Authors:
PETERS BS
CHEINGSONGPOPOV R
CALLOW D
FOXALL R
PATOU G
HODGKIN K
WEBER JN
Citation: Bs. Peters et al., A PILOT PHASE-II STUDY OF THE SAFETY AND IMMUNOGENICITY OF HIV P17 P24-VLP (P24-VLP) IN ASYMPTOMATIC HIV-SEROPOSITIVE SUBJECTS/, The Journal of infection, 35(3), 1997, pp. 231-235
Authors:
PETERS BS
THOMAS BJ
YI C
BECK EJ
WEBER J
PINCHING AJ
TAYLORROBINSON D
Citation: Bs. Peters et al., CHLAMYDIA-TRACHOMATIS AS A POSSIBLE COFACTOR FOR KAPOSIS-SARCOMA IN AIDS, International journal of STD & AIDS, 6(6), 1995, pp. 422-425
Authors:
PETERS BS
CARLIN E
WESTON RJ
LOVELESS SJ
SWEENEY J
WEBER J
MAIN J
Citation: Bs. Peters et al., ADVERSE-EFFECTS OF DRUGS USED IN THE MANAGEMENT OF OPPORTUNISTIC INFECTIONS ASSOCIATED WITH HIV-INFECTION, Drug safety, 10(6), 1994, pp. 439-454